Welcome to LookChem.com Sign In|Join Free

CAS

  • or
1H-Indole-2-carboxylic acid, 5-methyl-, methyl ester is a heterocyclic chemical compound with the molecular formula C11H11NO2. It is an ester derivative of 5-methyl-1H-indole-2-carboxylic acid, known for its potent biological activities and wide applications in the pharmaceutical industry.

102870-03-1

Post Buying Request

102870-03-1 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

102870-03-1 Usage

Uses

Used in Pharmaceutical Industry:
1H-Indole-2-carboxylic acid, 5-methyl-, methyl ester is used as a building block for the synthesis of various pharmaceuticals and bioactive compounds. Its unique structure and properties make it a valuable component in the development of drugs for the treatment of various diseases.
Used in Drug Development for Cancer Treatment:
In the field of oncology, 1H-Indole-2-carboxylic acid, 5-methyl-, methyl ester is utilized in the development of drugs targeting cancer cells. Its biological activities contribute to the inhibition of tumor growth and the modulation of signaling pathways associated with cancer progression.
Used in Drug Development for Inflammation Treatment:
This ester derivative is also employed in the creation of anti-inflammatory drugs, leveraging its potential to modulate immune responses and reduce inflammation in various conditions.
Used in Drug Development for Neurological Disorders:
1H-Indole-2-carboxylic acid, 5-methyl-, methyl ester is used in the research and development of pharmaceuticals aimed at treating neurological disorders. Its role in these applications is attributed to its ability to interact with specific receptors and pathways in the nervous system.
Used as a Research Tool:
In addition to its practical applications, 1H-Indole-2-carboxylic acid, 5-methyl-, methyl ester serves as a valuable research tool for studying the biological activities and mechanisms of action of indole-based compounds, furthering scientific understanding and innovation in medicinal chemistry.

Check Digit Verification of cas no

The CAS Registry Mumber 102870-03-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,0,2,8,7 and 0 respectively; the second part has 2 digits, 0 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 102870-03:
(8*1)+(7*0)+(6*2)+(5*8)+(4*7)+(3*0)+(2*0)+(1*3)=91
91 % 10 = 1
So 102870-03-1 is a valid CAS Registry Number.

102870-03-1SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name methyl 5-methyl-1H-indole-2-carboxylate

1.2 Other means of identification

Product number -
Other names 5-Methylindole-2-carboxylic acid methyl ester

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:102870-03-1 SDS

102870-03-1Relevant articles and documents

Palladium(0)-Catalyzed Intermolecular Asymmetric Cascade Dearomatization Reaction of Indoles with Propargyl Carbonate

Ding, Lu,Gao, Run-Duo,You, Shu-Li

supporting information, p. 4330 - 4334 (2019/02/25)

An intermolecular asymmetric cascade dearomatization reaction of indole derivatives with propargyl carbonate was developed. The challenges associated with both the chemoselectivity between the carbon and nitrogen nucleophile and the enantioselective control during the formation of an all-carbon quaternary stereogenic center were well addressed by a Pd catalytic system derived from the Feringa ligand. A series of enantioenriched multiply substituted fused indolenines were provided in good yields (71–86 %) with excellent enantioselectivity (91–96 % ee) and chemoselectivity (3/4>19:1 in most cases).

Iodine-mediated one-pot synthesis of indoles and 3-dimethylaminoindoles via annulation of enaminones

Jerezano, Alberto V.,Labarrios, Ehecatl M.,Jimenez, Fabiola E.,Del Cruz, Maria Carmen,Pazos, Diana C.,Gutierrez, Rsuini U.,Delgado, Francisco,Tamariz, Joaquin

, p. 18 - 53 (2014/03/21)

The synthesis of 2-carbonylindoles was achieved via a iodine-mediated cyclization of the corresponding enaminone precursors, which were formed by reaction of the ?-arylaminomethylene carbonyl derivatives with N,N'-dimethylformamide dimethyl acetal (DMFDMA). An alternative and more efficient procedure consisted of a similar cyclization of the enaminones, but under solvent-free and grinding reaction conditions. In another iodine-promoted procedure, 2-carbonyl-3-dimethylaminoindoles were synthesized via a one-pot cascade reaction between the α-arylaminomethylene carbonyl derivative and DMFDMA.ARKAT-USA, Inc.

Synthesis of carbazoles by gold(I)-catalyzed carbocyclization of 2-(enynyl)indoles

Praveen, Chandrasekaran,Perumal, Paramasivan Thirumalai

scheme or table, p. 521 - 524 (2011/04/17)

A new synthetic protocol for carbazoles through gold(I)-catalyzed intramolecular hydroarylation of (Z)-2-(enynyl)indoles was achieved in good yields. The requisite (Z)-2-(enynyl)indoles were synthesized stereoselectively by trimethylgallium-promoted, Z-selective Wittig olefination of N-alkylindole-2-carboxaldehydes with propargyl ylides. Substrates possessing both alkyl as well as aromatic groups are well tolerated under these reaction conditions. Georg Thieme Verlag Stuttgart.

Regioselective and versatile synthesis of indoles via intramolecular Friedel-Crafts heteroannulation of enaminones

Cruz, María Del Carmen,Jiménez, Fabiola,Delgado, Francisco,Tamariz, Joaquín

, p. 749 - 755 (2007/10/03)

A new approach is described for the synthesis of substituted indoles 5, through an intramolecular and regioselective Friedel-Crafts cyclization of enaminones 6a-h catalyzed by Lewis acids. Compounds 6 were prepared from the 2-anilinocarbonyl compounds 7, by treatment with DMFDMA under thermal or microwave (MW) irradiation conditions. An alternative and shorter one-pot two-step synthesis of indoles 5 was achieved starting from compounds 7 and promoted by MW radiation, including the elusive 2-acetylindoles 5i-m. Georg Thieme Verlag Stuttgart.

Probing the subpockets of factor Xa reveals two binding modes for inhibitors based on a 2-carboxyindole scaffold: A study combining structure-activity relationship and X-ray crystallography

Nazaré, Marc,Will, David W.,Matter, Hans,Schreuder, Herman,Ritter, Kurt,Urmann, Matthias,Essrich, Melanie,Bauer, Armin,Wagner, Michael,Czech, J?rg,Lorenz, Martin,Laux, Volker,Wehner, Volkmar

, p. 4511 - 4525 (2007/10/03)

Structure-activity relationships within a series of highly potent 2-carboxyindole-based factor Xa inhibitors incorporating a neutral P1 ligand are described with particular emphasis on the structural requirements for addressing subpockets of the factor Xa enzyme. Interactions with the subpockets were probed by systematic substitution of the 2-carboxyindole scaffold, in combination with privileged P1 and P4 substituents. Combining the most favorable substituents at the indole nucleus led to the discovery of a remarkably potent factor Xa inhibitor displaying a Ki value of 0.07 nM. X-ray crystallography of inhibitors bound to factor Xa revealed substituent-dependent switching of the inhibitor binding mode and provided a rationale for the SAR obtained. These results underscore the key role played by the P1 ligand not only in determining the binding affinity of the inhibitor by direct interaction but also in modifying the binding mode of the whole scaffold, resulting in a nonlinear SAR.

Protein kinase and phosphatase inhibitors and methods for designing them

-

, (2008/06/13)

The present invention provides a method for identifying inhibitors of protein kinases and/or protein phosphatases. Methods are also provided for inhibiting protein kinase and/or protein phosphatase activity. Specific non-peptide protein tyrosine kinase and/or protein phosphatase inhibitors are provided. The protein kinase or protein phosphatase inhibitors of the present invention may be used to treat a number of conditions in patients, including cancer, psoriasis, arthrosclerosis, immune system activity, Type II diabetes, and obesity.

Tripeptidylpeptidase inhibitors

-

, (2008/06/13)

A compound of formula wherein the substituents are defined as in the specification and salts or hydrates thereof is disclosed as well as a method of treating disorders associated with the inactivation or excessive degradation of cholecystokinin.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 102870-03-1